96MO A risk analysis of alpelisib (ALP)-induced hyperglycemia (HG) using baseline factors in patients (pts) with advanced solid tumours and breast cancer (BC): A pooled analysis of X2101 and SOLAR-1
- Resource Type
- Abstract
- Source
- In
Annals of Oncology May 2021 32 Supplement 2:S64-S64 - Subject
- Language
- ISSN
- 0923-7534